JSCO Frontier Symposium Abstract submission guidelines

TOP > JSCO Frontier Symposium Abstract submission guidelines

 

【JSCO Frontier Symposium
Abstract submission guidelines】

 

JSCO Frontier Symposium Abstract submission guidelines

JSCO2025 will hold the “Frontier” session, aiming to make JSCO’s annual meeting a platform for presenting groundbreaking evidence from clinical trials.
We invite you to submit abstracts to the session after reviewing the session outline and submission guidelines below.

 

Session outline (planned)

・Language: English only (including abstracts, slides, presentations and Q&A)
・Presentation length: Approximately 10-15 minutes per abstract (including Q&A)
・For each category, discussions will be held with the chairperson, presenters and discussants appointed by JSCO2025.

 

Note:
Abstracts must report new information not previously presented elsewhere.
We encourage abstracts in a wide range of areas, e.g. gastroenterology, hepatology, surgery, urology, gynecology, head and neck surgery, respiratory and rare diseases.
Abstracts not selected for the Frontier session will be considered for a relevant international session.
This session will be held in hybrid format, in person and online.
Delegates outside Japan who wish to attend (online) only this session can attend free of charge (pre-registration is required).

 

Submission guidelines

1. Eligibility
All first authors must be JSCO members, except for those submitting an abstract from outside of Japan.
2. Abstracts must not have been published or presented elsewhere.
3. Abstract character limit and other requirements:
Total number of authors
(first author and co-authors)		 Up to 15 authors
Total number of affiliations Up to 15 affiliations
Abstract title English: Up to 200 characters (including spaces)
Abstract body English: Up to 2,000 characters (including spaces) must be strictly adhered to.
Please do not include tables or figures.
Presentation language English
Conflict of interest Presenters at the annual meetings of JSCO are required to confirm whether the first author has any conflicts of interest (COI) within three years prior to the submission of the abstract. (Disclosures are not required for co-authors.)
For a detailed explanation of the COI, please read the abstract submission form and select the appropriate response to indicate whether you have any conflicts of interest. You will be requested to include a slide disclosing conflicts of interest at the end of the presentation.

Click here for details >> Disclosure of COI 
4. Abstract submission period:
February 10 (Mon)
 - 
Early August, 2025

Online Abstract Submission System

 
5. Notification of Acceptance or Rejection
Notification of acceptance or rejection of the abstract will be sent to you by email by late August.